📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.
TL;DR
A new mobile app designed to guide adults through vertigo repositioning maneuvers is in development, targeting self-treatment of BPPV. It aims to improve accuracy, symptom tracking, and reduce relapse, with potential adoption by ENT clinics.
A new vertigo relief app is in development to assist adults suffering from benign paroxysmal positional vertigo (BPPV) in performing repositioning maneuvers at home, potentially reducing relapse rates and easing clinic demand. The app aims to guide users through maneuvers like Epley and Brandt-Daroff with real-time head-angle feedback, symptom logging, and instructional support, making self-treatment more accurate and accessible.
The app is designed for adults, primarily women and older individuals, who experience recurrent BPPV episodes. It will include a screening tool, animated step-by-step guidance with audio cues, and gyroscope-based head position tracking to ensure correct maneuver execution. Users will be able to log dizziness episodes, triggers, and severity over time, providing valuable data for managing their condition.
Developers plan to offer a freemium model, where basic maneuver guidance is free, and premium features like detailed symptom tracking, history export, and reminders are available via subscription. Additionally, ENT clinics, audiologists, and vestibular physiotherapists could license the app for patient use, integrating it into their treatment protocols.
The initiative aligns with a broader shift toward telehealth and digital therapeutics, driven by increased acceptance of remote care solutions during and after the COVID-19 pandemic. The digital vestibular rehabilitation market was valued near USD 498 million in 2024, with growth expected to continue at a compound annual rate of approximately 13.5% through 2033. Learn more about related telehealth solutions.
Potential Impact on BPPV Self-Management and Clinical Practice
This app could significantly improve self-treatment accuracy for BPPV, potentially reducing relapse rates and decreasing the need for in-clinic visits. It offers a scalable solution that could complement existing care pathways, especially in areas with long wait times for specialists. If adopted widely, it could also foster better symptom tracking and patient engagement in managing vestibular disorders.
Epley maneuver head position tracker
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Growing Demand for Digital Solutions in Vestibular Care
Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder, yet many sufferers face challenges performing repositioning maneuvers correctly at home. Traditionally, treatment involves in-person visits with specialists, but the pandemic accelerated a shift toward remote care and self-management tools. Smartphones now possess sensors capable of measuring head angles in real time, opening opportunities for digital therapeutics in vestibular rehabilitation.
The market for digital vestibular therapies was estimated at nearly USD 498 million in 2024, with a projected growth rate of over 13% annually through 2033, reflecting increasing acceptance among providers and payers. Pilot programs and early-stage apps have shown promise, but widespread adoption depends on clinical validation and integration into existing care models.
“The integration of gyroscope sensors with guided maneuvers could transform how patients self-manage BPPV, making treatment more accessible and effective.”
— an anonymous researcher
FHUILIJH Right,20cm, Semicircular Canal Model – Otolitosis Teaching Model – Cochlear Vestibular Rehabilitation Model for Study Visualization Didactic Tool
The model is a simple, intuitive, transparent, hollow, image otolitosis teaching model, suitable for academic conference communication.
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Uncertainties Around Clinical Validation and Adoption
It remains unclear how effectively the app will perform in real-world settings, including user adherence, accuracy of head-angle feedback, and clinical validation of its safety and efficacy. The willingness of clinics and healthcare providers to recommend or license the app is also still being tested through pilot programs.
DizzyFIX Vertigo Relief Trainer for Benign Paroxysmal Positional Vertigo or BPPV, Inner Ear Balance Device for Particle Repositioning Maneuver, Non-Drug Solution & Relieves Dizziness
REGAIN INNER EAR BALANCE: The DizzyFIX Vertigo Relief Trainer is a revolutionary device that can help people suffering…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps for Development, Testing, and Market Entry
Developers plan to launch a lightweight landing page and a guided Epley maneuver demo to gauge user interest and collect early feedback. They will also conduct targeted advertising campaigns to validate demand among consumers and clinics. Further, they aim to approach 10-15 ENT and vestibular clinics to pilot the app as part of their patient home care programs, assessing clinical integration and provider acceptance.
DizzyFIX Vertigo Relief Trainer for Benign Paroxysmal Positional Vertigo or BPPV, Inner Ear Balance Device for Particle Repositioning Maneuver, Non-Drug Solution & Relieves Dizziness
REGAIN INNER EAR BALANCE: The DizzyFIX Vertigo Relief Trainer is a revolutionary device that can help people suffering…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How will the app ensure users perform maneuvers correctly?
The app will use gyroscope sensors in smartphones to provide real-time head-angle feedback, along with animated and audio guidance to support proper execution of maneuvers like Epley.
Is this app a replacement for seeing a doctor?
No, the app is designed as a supplementary tool. It includes a disclaimer emphasizing that it is not a substitute for professional medical advice and prompts users to consult a healthcare provider if red-flag symptoms occur.
Will the app be available for both iOS and Android?
Yes, the initial development plans include both iOS and Android platforms to maximize accessibility for users.
How will clinics incorporate this app into their practice?
Clinics can license the app for patient use between visits, guiding self-treatment and tracking symptoms remotely, which may help reduce in-clinic visits and improve patient engagement.
What is the timeline for the app’s release?
The development is ongoing, with initial testing phases planned in the coming months. A full commercial launch is expected after validation and pilot testing are completed.
Source: IdeaNavigator AI
